nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00864	0.0613	CbGeAlD
Fesoterodine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00854	0.0606	CbGeAlD
Fesoterodine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00832	0.059	CbGeAlD
Fesoterodine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00777	0.0551	CbGeAlD
Fesoterodine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00722	0.0512	CbGeAlD
Fesoterodine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00696	0.0493	CbGeAlD
Fesoterodine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00675	0.0479	CbGeAlD
Fesoterodine—CHRM4—brain—attention deficit hyperactivity disorder	0.00661	0.0468	CbGeAlD
Fesoterodine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00657	0.0466	CbGeAlD
Fesoterodine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.0065	0.0461	CbGeAlD
Fesoterodine—CHRM5—brain—attention deficit hyperactivity disorder	0.00516	0.0366	CbGeAlD
Fesoterodine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00464	0.0329	CbGeAlD
Fesoterodine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00446	0.0317	CbGeAlD
Fesoterodine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00422	0.0299	CbGeAlD
Fesoterodine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00406	0.0288	CbGeAlD
Fesoterodine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00378	0.0268	CbGeAlD
Fesoterodine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00376	0.0267	CbGeAlD
Fesoterodine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00364	0.0258	CbGeAlD
Fesoterodine—CHRM2—brain—attention deficit hyperactivity disorder	0.00354	0.0251	CbGeAlD
Fesoterodine—CHRM1—brain—attention deficit hyperactivity disorder	0.00323	0.0229	CbGeAlD
Fesoterodine—CHRM3—brain—attention deficit hyperactivity disorder	0.00289	0.0205	CbGeAlD
Fesoterodine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00271	0.0192	CbGeAlD
Fesoterodine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00229	0.0162	CbGeAlD
Fesoterodine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00208	0.0147	CbGeAlD
Fesoterodine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00204	0.0145	CbGeAlD
Fesoterodine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.002	0.0142	CbGeAlD
Fesoterodine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00197	0.0139	CbGeAlD
Fesoterodine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00192	0.0136	CbGeAlD
Fesoterodine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00179	0.0127	CbGeAlD
Fesoterodine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00156	0.0111	CbGeAlD
Fesoterodine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00147	0.0104	CbGeAlD
Fesoterodine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00141	0.01	CbGeAlD
Fesoterodine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00138	0.0098	CbGeAlD
Fesoterodine—ABCB1—brain—attention deficit hyperactivity disorder	0.00112	0.00796	CbGeAlD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000689	0.000803	CbGpPWpGaD
Fesoterodine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000675	0.000786	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000671	0.000782	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000664	0.000773	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000662	0.00077	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00066	0.000769	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000655	0.000763	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000628	0.000731	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000626	0.000729	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000621	0.000723	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000619	0.00072	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000613	0.000713	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000595	0.000693	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000591	0.000688	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000589	0.000686	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000583	0.000679	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000579	0.000674	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000577	0.000672	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000577	0.000672	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000575	0.00067	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000572	0.000665	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00057	0.000664	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00057	0.000663	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000559	0.000651	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000557	0.000649	CbGpPWpGaD
Fesoterodine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000553	0.000643	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000552	0.000642	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000549	0.00064	CbGpPWpGaD
Fesoterodine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000549	0.000639	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000548	0.000638	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000547	0.000637	CbGpPWpGaD
Fesoterodine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000545	0.000635	CbGpPWpGaD
Fesoterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000543	0.000632	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000543	0.000632	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000542	0.000631	CbGpPWpGaD
Fesoterodine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000541	0.00063	CbGpPWpGaD
Fesoterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000541	0.00063	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000541	0.00063	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000541	0.000629	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000537	0.000625	CbGpPWpGaD
Fesoterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000536	0.000624	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000536	0.000624	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000535	0.000623	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00053	0.000617	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000526	0.000612	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000525	0.000611	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000524	0.00061	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000524	0.00061	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00052	0.000606	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000519	0.000604	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000518	0.000603	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000517	0.000601	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000505	0.000588	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000504	0.000587	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000503	0.000585	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000499	0.000581	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000498	0.00058	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000484	0.000563	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000473	0.00055	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000472	0.00055	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000471	0.000549	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00047	0.000547	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000468	0.000545	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000467	0.000543	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000465	0.000541	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000463	0.000539	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000463	0.000539	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000461	0.000536	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00046	0.000536	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000459	0.000534	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000455	0.000529	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000452	0.000527	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000452	0.000526	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00045	0.000524	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000449	0.000522	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000441	0.000514	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000441	0.000513	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000439	0.000511	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000435	0.000507	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000433	0.000504	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000425	0.000495	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000424	0.000494	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000424	0.000493	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000421	0.00049	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000418	0.000487	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000413	0.000481	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000407	0.000474	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000406	0.000472	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000401	0.000467	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0004	0.000466	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0004	0.000466	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000396	0.000461	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000395	0.00046	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000385	0.000448	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000378	0.00044	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000369	0.00043	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000368	0.000429	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000368	0.000428	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000364	0.000424	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000364	0.000424	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000363	0.000423	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000361	0.000421	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00036	0.000419	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000359	0.000418	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000356	0.000415	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000354	0.000412	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000353	0.000411	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000351	0.000409	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000351	0.000408	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00035	0.000407	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000349	0.000407	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000346	0.000403	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000326	0.00038	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000325	0.000378	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000322	0.000375	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000319	0.000372	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000319	0.000371	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000318	0.00037	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000317	0.000369	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000316	0.000368	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000316	0.000368	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000315	0.000367	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000314	0.000366	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000313	0.000364	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000312	0.000363	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000311	0.000362	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00031	0.000361	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00031	0.00036	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000309	0.00036	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000307	0.000357	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000307	0.000357	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000306	0.000357	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000306	0.000356	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000306	0.000356	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000305	0.000355	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000304	0.000353	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000303	0.000352	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000301	0.00035	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000297	0.000345	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000296	0.000345	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000295	0.000344	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000292	0.00034	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000287	0.000334	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000286	0.000333	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000286	0.000333	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000285	0.000331	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000284	0.000331	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000283	0.00033	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000282	0.000328	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000282	0.000328	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000281	0.000327	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000279	0.000325	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000278	0.000324	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000278	0.000324	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000278	0.000323	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000275	0.00032	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000269	0.000314	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000267	0.000311	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000261	0.000304	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000261	0.000304	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000259	0.000302	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000259	0.000302	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000259	0.000301	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000258	0.0003	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000257	0.000299	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000256	0.000298	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000252	0.000293	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000251	0.000293	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000248	0.000289	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000247	0.000288	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000244	0.000284	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000241	0.00028	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00024	0.000279	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000239	0.000278	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000237	0.000275	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000234	0.000272	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000231	0.000269	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000227	0.000265	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000226	0.000263	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000218	0.000253	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000215	0.000251	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000215	0.00025	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000213	0.000247	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000209	0.000243	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.0002	0.000233	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000199	0.000232	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000199	0.000231	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000197	0.00023	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000188	0.000219	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000188	0.000218	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000186	0.000216	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000182	0.000212	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000181	0.000211	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000179	0.000209	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000175	0.000204	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000174	0.000203	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000173	0.000201	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000169	0.000197	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000169	0.000197	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000167	0.000195	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.000194	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000166	0.000193	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000166	0.000193	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000166	0.000193	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000164	0.000191	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000164	0.000191	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000164	0.000191	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000163	0.00019	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000162	0.000189	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000159	0.000185	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000158	0.000184	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000157	0.000183	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000156	0.000182	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000156	0.000182	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000153	0.000179	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000153	0.000178	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000153	0.000178	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000152	0.000177	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000151	0.000176	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000151	0.000176	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000148	0.000172	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000143	0.000166	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000132	0.000154	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.000147	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000125	0.000145	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000138	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000107	0.000125	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000107	0.000125	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000106	0.000123	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000102	0.000119	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000102	0.000119	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0001	0.000117	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.0001	0.000117	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.96e-05	0.000116	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	9.45e-05	0.00011	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.38e-05	0.000109	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.33e-05	0.000109	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.43e-05	9.82e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.15e-05	9.49e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.08e-05	9.4e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.76e-05	9.04e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.78e-05	7.89e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.18e-05	7.19e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.14e-05	7.14e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.69e-05	6.62e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.67e-05	6.6e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.61e-05	6.53e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.3e-05	5.01e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.05e-05	4.72e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.65e-05	3.08e-05	CbGpPWpGaD
